Regulation of Neurotransmitter Action by Steroid Hormones in Females

类固醇激素对女性神经递质作用的调节

基本信息

  • 批准号:
    9036844
  • 负责人:
  • 金额:
    $ 192.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-04-01 至 2021-08-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Changing levels of the ovarian hormones 17β-estradiol (E2) and progesterone (PROG), together with their neuroactive metabolites, have essential actions on the central nervous system (CNS). Many of the CNS effects involve memory and mood disorders such as those found in women after menopause, or the cognitive and psychiatric symptoms frequently present during specific stages of the menstrual cycle. Yet, little is known about how large swings in ovarian hormone levels affect the coordination of neuronal ensembles in the brain during behavior and how particular abnormalities may ensue at the cellular or molecular level. This proposal focuses on the function of parvalbumin-positive (PV+) interneurons (INs) as collective mediators of cognitive and emotional states associated with altered ovarian hormone levels. These cells and the networks they control are critically involved in sharp-wave ripples (SPW-R) and γ-oscillations (30-120 Hz), brain rhythms essential for memory recall, cognition, and information processing. We hypothesize that E2 and PROG act on PV+INs through distinct mechanisms to alter SPW-R, γ-oscillatory activity, and/or phase-amplitude coupling between θ (5-10 Hz) and γ-oscillations. Two novel mechanisms will be investigated: the function of δ subunit- containing γ-amino-butyric-acid receptors (δ-GABAARs) of PV+INs as a target for PROG-derived neurosteroids (NS); and the signaling cascade formed by the G-protein coupled E2 receptor (GPER-1) → neuregulin 1 (NRG-1) → endothelial growth factor receptor tyrosine kinase (ErbB4), for E2. Two periods of ovarian hormonal alterations will be examined in mice. The first is the physiological ovarian cycle in which E2 and PROG levels rapidly swing up and down over a typical cycle period of 4-6 days. The second is a genuine model of human menopause in mice, that is, the selective attrition of small primordial and primary ovarian follicles by the industrial chemical 4-vinylcyclohexene diepoxide (VCD) that has negligible effects on other tissues. These studies will provide the experimental underpinnings of the first comprehensive and unifying model of ovarian hormone action on neuronal oscillations underlying cognition and working memory. Sophisticated electrophysiological and optogenetic experiments in vivo and in vitro, genetic manipulations, pharmacological approaches never before tested for effects on neuronal ensembles, and morphological/immunohistochemical studies carried out for the first time in this context will converge in the proposal. This multifaceted and novel approach is expected to provide unique insights into the actions of ovarian hormonal changes on the female brain. The studies have a high translational potential as they will shed light on possible treatments for millions suffering from menstrual cycle-related neurological and psychiatric dysfunction (pre-menstrual syndrome, PMS, and pre-menstrual dysphoric disorder, PMDD), and may provide explanation for the cognitive decline and high prevalence of sporadic Alzheimer's disease (AD) in post-menopausal women.
 性状(由申请方提供):卵巢激素17β-雌二醇(E2)和孕酮(PROG)及其神经活性代谢物水平的变化对中枢神经系统(CNS)具有重要作用。许多中枢神经系统的影响涉及记忆和情绪障碍,如绝经后的妇女,或在月经周期的特定阶段经常出现的认知和精神症状。然而,人们对卵巢激素水平的大幅波动如何影响行为期间大脑中神经元集合的协调以及如何在细胞或分子水平上发生特定异常知之甚少。该建议的重点是小清蛋白阳性(PV+)中间神经元(IN)作为与卵巢激素水平改变相关的认知和情绪状态的集体介质的功能。这些细胞和它们控制的网络与锐波波纹(SPW-R)和γ振荡(30-120 Hz)密切相关,这是记忆回忆,认知和信息处理所必需的大脑节律。我们假设E2和PROG通过不同的机制作用于PV+INs,以改变SPW-R、γ振荡活动和/或θ(5-10 Hz)和γ振荡之间的相位-振幅耦合。将研究两种新机制:PV+ IN的含δ亚基的γ-氨基丁酸受体(δ-GABAAR)作为PROG衍生神经类固醇(NS)靶点的功能;以及G蛋白偶联E2受体(GPER-1)→神经调节蛋白1(NRG-1)→内皮生长因子受体酪氨酸激酶(ErbB 4)形成的E2信号级联。将在小鼠中检查卵巢激素变化的两个时期。第一个是生理性卵巢周期,其中E2和PROG水平在4-6天的典型周期内快速上下摆动。第二个是真正的人类更年期小鼠模型,即工业化学品4-乙烯基环己烯二环氧化物(VCD)对小原始和初级卵泡的选择性磨损,对其他组织的影响可以忽略不计。这些研究将为卵巢激素对认知和工作记忆神经元振荡作用的第一个全面和统一的模型提供实验基础。复杂的电生理学和光遗传学实验在体内和体外,遗传操作,药理学方法从未测试过对神经元合奏的影响,以及首次在这种情况下进行的形态学/免疫组织化学研究将在该提案中收敛。这种多方面的新颖方法有望为卵巢激素变化对女性大脑的作用提供独特的见解。这些研究具有很高的转化潜力,因为它们将为数百万患有月经周期相关神经和精神功能障碍(经前综合征,PMS和经前焦虑障碍,PMDD)的患者提供可能的治疗方法,并可能为认知能力下降和绝经后女性散发性阿尔茨海默病(AD)的高患病率提供解释。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Preferential enhancement of GluN2B-containing native NMDA receptors by the endogenous modulator 24S-hydroxycholesterol in hippocampal neurons.
海马神经元中内源性调节剂 24S-羟基胆固醇优先增强含有 GluN2B 的天然 NMDA 受体。
  • DOI:
    10.1016/j.neuropharm.2018.12.028
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    Wei,Xiaofei;Nishi,Toshiya;Kondou,Shinichi;Kimura,Haruhide;Mody,Istvan
  • 通讯作者:
    Mody,Istvan
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ISTVAN MODY其他文献

ISTVAN MODY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ISTVAN MODY', 18)}}的其他基金

Endogenous Gabaergic Activity
内源性伽巴能活性
  • 批准号:
    8573535
  • 财政年份:
    2012
  • 资助金额:
    $ 192.5万
  • 项目类别:
Targeting specific cortical microcircuit components to enhance functional recover
针对特定的皮质微电路组件以增强功能恢复
  • 批准号:
    8537523
  • 财政年份:
    2012
  • 资助金额:
    $ 192.5万
  • 项目类别:
Targeting specific cortical microcircuit components to enhance functional recover
针对特定的皮质微电路组件以增强功能恢复
  • 批准号:
    8426660
  • 财政年份:
    2012
  • 资助金额:
    $ 192.5万
  • 项目类别:
Structural and Functional Alterations of Interneurons in Models of Schizophrenia
精神分裂症模型中中间神经元的结构和功能改变
  • 批准号:
    8113673
  • 财政年份:
    2011
  • 资助金额:
    $ 192.5万
  • 项目类别:
Structural and Functional Alterations of Interneurons in Models of Schizophrenia
精神分裂症模型中中间神经元的结构和功能改变
  • 批准号:
    8263756
  • 财政年份:
    2011
  • 资助金额:
    $ 192.5万
  • 项目类别:
Identifying neurons and circuits critical for epileptogenesis
识别对癫痫发生至关重要的神经元和回路
  • 批准号:
    8459027
  • 财政年份:
    2011
  • 资助金额:
    $ 192.5万
  • 项目类别:
Identifying neurons and circuits critical for epileptogenesis
识别对癫痫发生至关重要的神经元和回路
  • 批准号:
    8300808
  • 财政年份:
    2011
  • 资助金额:
    $ 192.5万
  • 项目类别:
Identifying neurons and circuits critical for epileptogenesis
识别对癫痫发生至关重要的神经元和回路
  • 批准号:
    8179588
  • 财政年份:
    2011
  • 资助金额:
    $ 192.5万
  • 项目类别:
Regulations of Neurotransmitter Action by Steroid Hormones in Females
类固醇激素对女性神经递质作用的调节
  • 批准号:
    7858422
  • 财政年份:
    2007
  • 资助金额:
    $ 192.5万
  • 项目类别:
Regulations of Neurotransmitter Action by Steroid Hormones in Females
类固醇激素对女性神经递质作用的调节
  • 批准号:
    7317163
  • 财政年份:
    2007
  • 资助金额:
    $ 192.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 192.5万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 192.5万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 192.5万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 192.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 192.5万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 192.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 192.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 192.5万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 192.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 192.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了